Summary: MAPS Founder and Executive Director Rick Doblin, Ph.D., joins the Lex Fridman Podcast to discuss the history of psychedelic substances in culture and research, the ways in which MAPS is working …
Summary: MAPS Founder and Executive Director Rick Doblin, Ph.D., joins FOX News Radio’s Kennedy Saves the World Podcast to explain the results of MAPS’ first Phase 3 clinical trial investigating …
Summary: At a virtual event held to celebrate the legacy of psychedelic pioneers Alexander “Sasha” Shulgin and Ann Shulgin, MAPS Founder and Executive Director Rick Doblin, Ph.D., participated …
Summary: “When I started MAPS in 1986, I knew I wanted to use the word ‘psychedelic’ in the title,” recalls MAPS Founder and Executive Director Rick Doblin, Ph.D. “Even though …
Summary: MAPS Founder and Executive Director Rick Doblin, Ph.D., and Roland Griffiths, Ph.D., Founding Director of the Johns Hopkins Center for Psychedelic and Consciousness Research, join WYPR Baltimore’s …
Summary: Berra Yazar-Klosinski, Ph.D., of MAPS and MAPS Public Benefit Corporation (MAPS PBC) joins Nick Jikomes, Ph.D., on the Good Chemistry podcast to discuss how and why MDMA-assisted therapy is utilized …
Summary: “If you can feel this deeper connection that we’re a part of everything and everything is a part of us, it’ll be harder to dehumanize, demonize, and otherize people who are different …
Summary: On A Life of Greatness Podcast, Sarah Grynberg and I discuss the detrimental, decades-long impacts of the War on Drugs and how MAPS’ efforts are aimed to advance psychedelic research as …
Summary: Thank you to Joe Rogan for hosting MAPS Founder and Executive Director Rick Doblin, Ph.D., for his third appearance on the Joe Rogan Experience, one of the top podcasts in the world! Listen to …
Summary: Listen to MAPS Founder and Executive Director Rick Doblin, Ph.D., on The Recount’s Hell & High Water podcast, where he and John Heilemann discuss exciting developments in the field …
Summary: On the Brain Health podcast, host Dr. Nissen joins Rick Doblin, Ph.D., in his backyard to discuss the implications of MAPS’ first Phase 3 clinical trial of MDMA-assisted therapy for PTSD, …
Summary: Listen to MAPS Founder and Executive Director Rick Doblin, Ph.D., on the Drug Science Podcast, where he speaks with Professor David Nutt about MAPS’ 35-year history, current project updates, …